B
Journal
British journal of pharmacology
ISSN: 1476-5381
Titre abrégé: Br J Pharmacol
Pays: England
ID NLM: 7502536
Informations de publication
Date de publication:
08 2020
08 2020
Historique:
received:
10
06
2019
revised:
26
03
2020
accepted:
04
04
2020
pubmed:
27
4
2020
medline:
22
6
2021
entrez:
27
4
2020
Statut:
ppublish
Résumé
The entire kallikrein-kinin system is present in the skin, and it is thought to exert a relevant role in cutaneous diseases, including psoriasis. The present study was designed to evaluate the relevance of kinin receptors in the development and progression of a model of psoriasis in mice. The effects of kinin B Both kinin receptors were up-regulated following 6 days of imiquimod treatment. Kinin B Kinins exerted critical roles in imiquimod-induced psoriasis. Both B
Sections du résumé
BACKGROUND AND PURPOSE
The entire kallikrein-kinin system is present in the skin, and it is thought to exert a relevant role in cutaneous diseases, including psoriasis. The present study was designed to evaluate the relevance of kinin receptors in the development and progression of a model of psoriasis in mice.
EXPERIMENTAL APPROACH
The effects of kinin B
KEY RESULTS
Both kinin receptors were up-regulated following 6 days of imiquimod treatment. Kinin B
CONCLUSIONS AND IMPLICATIONS
Kinins exerted critical roles in imiquimod-induced psoriasis. Both B
Identifiants
pubmed: 32335893
doi: 10.1111/bph.15077
pmc: PMC7348090
doi:
Substances chimiques
Kinins
0
Receptor, Bradykinin B1
0
Receptor, Bradykinin B2
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
3535-3551Subventions
Organisme : Conselho Nacional de Desenvolvimento Científico e Tecnológico
ID : 157002/2018-7
Organisme : Conselho Nacional de Desenvolvimento Científico e Tecnológico
ID : 203667/2018-2
Organisme : Conselho Nacional de Desenvolvimento Científico e Tecnológico
ID : 445822/2014-7
Organisme : INCT-INOVAMED
ID : 465430/2014-7
Informations de copyright
© 2020 The British Pharmacological Society.
Références
J Biol Chem. 1995 Jun 9;270(23):13706-10
pubmed: 7775424
Exp Dermatol. 2016 Sep;25(9):694-700
pubmed: 27093919
Hippokratia. 2007 Jul;11(3):124-8
pubmed: 19582206
J Am Acad Dermatol. 2000 Jul;43(1 Pt 2):S6-11
pubmed: 10861101
Adv Immunol. 2017;136:29-84
pubmed: 28950949
J Cell Biochem. 2014 Nov;115(11):1985-95
pubmed: 24924235
Br J Pharmacol. 2019 Dec;176 Suppl 1:S21-S141
pubmed: 31710717
J Cereb Blood Flow Metab. 2011 Apr;31(4):991-3
pubmed: 21206507
Cell Mol Immunol. 2012 Jul;9(4):302-9
pubmed: 22705915
Ann Bot. 2011 May;107(7):1127-40
pubmed: 21169293
Ann Rheum Dis. 1986 Nov;45(11):921-4
pubmed: 2878644
Int Immunopharmacol. 2007 Dec 20;7(14):1862-8
pubmed: 18039523
Pharmacology. 2002 Nov;66(3):153-61
pubmed: 12372905
Br J Pharmacol. 1999 May;127(2):315-20
pubmed: 10385228
Br J Pharmacol. 2019 Dec;176 Suppl 1:S297-S396
pubmed: 31710714
Am J Ther. 2010 Jan-Feb;17(1):92-5
pubmed: 19531936
PLoS One. 2011;6(11):e27875
pubmed: 22132157
Br J Pharmacol. 2019 Nov;176(21):4081-4086
pubmed: 31441038
J Immunol. 2003 Jun 1;170(11):5349-53
pubmed: 12759407
F1000Res. 2016 Apr 28;5:
pubmed: 27158469
Br J Dermatol. 1991 Mar;124(3):236-41
pubmed: 1708271
Braz J Med Biol Res. 2000 Jun;33(6):665-77
pubmed: 10829095
Neuropeptides. 2010 Apr;44(2):155-61
pubmed: 20045189
ScientificWorldJournal. 2006 Oct 09;6:1247-61
pubmed: 17041716
Br J Pharmacol. 2018 Apr;175(7):987-993
pubmed: 29520785
Contrib Nephrol. 2011;170:145-155
pubmed: 21659767
Immunopharmacology. 1999 Sep;43(2-3):287-91
pubmed: 10596865
J Pharmacol Exp Ther. 2004 May;309(2):661-9
pubmed: 14747609
Autoimmun Rev. 2017 Feb;16(2):192-207
pubmed: 27988430
Nucleic Acids Res. 2018 Jan 4;46(D1):D1091-D1106
pubmed: 29149325
Int Immunopharmacol. 2008 Feb;8(2):135-42
pubmed: 18182216
FEBS Lett. 1989 Apr 24;247(2):189-92
pubmed: 2541011
Clin Dermatol. 2007 Nov-Dec;25(6):606-15
pubmed: 18021899
J Immunol. 2012 Jan 1;188(1):462-9
pubmed: 22131335
J Invest Dermatol. 2005 Jan;124(1):178-86
pubmed: 15654972
Br J Dermatol. 2007 Apr;156(4):642-5
pubmed: 17263818
Br J Pharmacol. 2020 Aug;177(15):3535-3551
pubmed: 32335893
Genome Med. 2017 Mar 9;9(1):24
pubmed: 28279190
Int J Mol Sci. 2018 Jan 08;19(1):
pubmed: 29316717
Dermatologica. 1989;179 Suppl 1:116-7
pubmed: 2673852
J Dermatol Sci. 2016 May;82(2):95-105
pubmed: 26817699
Br J Pharmacol. 2003 Jan;138(1):13-22
pubmed: 12522068
Pain. 2000 Jul;87(1):1-5
pubmed: 10863040
J Leukoc Biol. 2000 Nov;68(5):587-92
pubmed: 11073095
PLoS Pathog. 2016 Nov 4;12(11):e1005952
pubmed: 27814401
J Am Acad Dermatol. 1993 Mar;28(3):490-2
pubmed: 8267693
J Neurosci Methods. 2014 Aug 30;234:139-46
pubmed: 24525328
Arch Dermatol Res. 1993;285(7):393-6
pubmed: 8304779
Br J Dermatol. 2008 Sep;159(4):792-803
pubmed: 18717683
Br J Pharmacol. 2004 Dec;143(7):803-18
pubmed: 15520046
Br J Pharmacol. 2018 Feb;175(3):407-411
pubmed: 29350411
Proc Natl Acad Sci U S A. 2000 Jul 5;97(14):8140-5
pubmed: 10859349
J Dermatol. 2014 Feb;41(2):135-43
pubmed: 24387343
Cell Commun Adhes. 2011 Aug;18(4):67-71
pubmed: 21942713
Dermatologica. 1990;181(1):51-3
pubmed: 2203659
Int Immunopharmacol. 2002 Dec;2(13-14):1721-7
pubmed: 12489785
J Neuroinflammation. 2008 Nov 05;5:49
pubmed: 18986535
J Invest Dermatol. 1990 Dec;95(6):705-10
pubmed: 2174449
J Dermatol Sci. 2011 Oct;64(1):23-30
pubmed: 21840178
Biochem Biophys Res Commun. 1998 Apr 17;245(2):307-12
pubmed: 9571146
Eur J Pharmacol. 2007 Nov 14;573(1-3):221-9
pubmed: 17669394
Biochem Biophys Res Commun. 2011 Dec 16;416(3-4):266-9
pubmed: 22079285
J Am Acad Dermatol. 2018 Jan;78(1):70-80
pubmed: 29102053
J Immunol. 2009 May 1;182(9):5836-45
pubmed: 19380832
Allergy. 2011 Nov;66(11):1397-406
pubmed: 21859431
Front Immunol. 2018 Feb 02;9:156
pubmed: 29456540
Protoplasma. 2016 Mar;253(2):503-15
pubmed: 26016607